Pfizer CEO Albert Bourla appeared on CNBC's "Mad Money" to discuss the company's earnings. He attributed lower COVID-19 vaccine uptake to "vaccine fatigue" and "anti-vaxxer rhetoric," while Jim Cramer expressed confusion over why more people are not following his lead in getting boosted.






